AND019

· Kind Pharmaceuticals LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AND019, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer [Phase 1]